Barely Significant
← all excerpts

GammaTile® brachytherapy in the treatment of recurrent glioblastomas.

Neurooncol Adv · 2022 · PMC8788013 · PMID 35088050

Europe PMCDOI
1
hedged sentence
0.0506
closest p · 1.0× alpha
0.0506
boldest claim

The sentences

did not reach statistical significanceP = 0.0506so close (0.05 < p ≤ 0.1)
The median PFS for the GT-treated patients was lengthened relative to the control cohort (8.2 versus 5.1 months) but did not reach statistical significance ( P = 0.0506; Figure 4A ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.